AstraZeneca

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

3 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Global Markets & Equities 07 Oct 2026, 08:14 AM IST

AstraZeneca bets on Kendall Square R&D hub to power next phase of growth

AstraZeneca has opened a major research and development center in Cambridge’s Kendall Square, a move that underscores the drugmaker’s determination to deepen its U.S. innovation footprint and sustain growth well beyond the current decade. The company says the site, backed by more than $1 billion in investment in Massachusetts, is designed to accelerate discovery with advanced automation, robotics and a denser concentration of scientific talent.

By RDU Global Wire5 min read

Global Health & Biotech06 Oct 2026, 08:29 AM IST

AstraZeneca CEO Says Summit Drug Could Anchor Next Wave of Cancer Combinations After $2 Billion Bet

AstraZeneca Chief Executive Pascal Soriot said Summit Therapeutics’ cancer drug could become a foundation for the next generation of combination therapies, underscoring why the Anglo-Swedish drugmaker has committed about $2 billion to the biotech. The comments come as AstraZeneca and Daiichi Sankyo move to test Summit’s ivonescimab alongside Datroway, a sign that large pharmaceutical groups are racing to secure the most promising assets in oncology.

5 min readRead →

Healthcare, Pharma & Life SciencesRecently

Medico Remedies Among Five Healthcare Stocks to Hit 52-Week Lows as Sensex Slips 242 Points

Indian healthcare counters came under renewed pressure on Thursday, with five BSE Healthcare Index stocks touching fresh 52-week lows as the Sensex fell 242 points to 72,529. Medico Remedies, Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India and Eris Lifesciences all marked their weakest levels in a year, underscoring the depth of the sector’s recent correction. Several of these names have now shed as much as 48% in a month, reflecting sustained selling in defensive pockets of the market.

4 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside AstraZeneca:

Pascal Soriot(2)Washington, D.C.(1)Summit Therapeutics(1)Kendall Square(1)Daiichi Sankyo(1)Cambridge, Massachusetts(1)